Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian–Swedish Women's Lifestyle and Health Cohort Study-Reference-Cited by-同舟云学术

Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian–Swedish Women's Lifestyle and Health Cohort Study

Published:2004-03-09 Issue:7 Volume:90 Page:1386-1391
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kumle M,Weiderpass E,Braaten T,Adami H-O,Lund E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6601715.pdf

Reference28 articles.

1. Adami HO, Bergstrom R, Persson I, Sparen P (1990) The incidence of ovarian cancer in Sweden, 1960–1984. Am J Epidemiol 132: 446–452

2. Beral V, Hannaford P, Kay C (1988) Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study. Lancet 2: 1331–1335

3. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G (1999) Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ 318: 96–100

4. Bjorge T, Engeland A, Hansen S, Trope CG (1997) Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954–1993. Int J Cancer 71: 780–786

5. Centers for Disease Control Cancer Steroid Hormone Study (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med 316: 650–655

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-07-17

2. Assessing the impact of contraceptive use on cancer risk among women of reproductive age – a systematic review;2023-08-31

3. Update on Contraception;Journal of Women's Health;2023-04-01

4. FSRH Guideline (August 2022) Progestogen-only Pills;BMJ Sexual & Reproductive Health;2022-08

5. Systematic review and meta‐analysis on the impact of the levonorgestrel‐releasing intrauterine system in reducing risk of ovarian cancer;International Journal of Gynecology & Obstetrics;2021-06-08